Skip to main content

Table 1 Neurological abnormalities in XP-CS patients

From: Xeroderma pigmentosum-Cockayne syndrome complex

Clinical feature

#/total (%)

Intellectual disability

38/38 (100)

Progressive neurological problems

26/26 (100)

Ataxia, any form (sometimes unspecified)

15/15 (100)

Microcephaly

30/32 (94)

Abnormalities of myelination (CNS)

14/15 (93)

Brain atrophy or ventriculomegaly

19/21 (90)

Hearing loss (sensorineural)

18/21 (86)

Slowed nerve conduction velocity

12/14 (86)

Seizures

8/11 (73)

Brain calcifications

10/16 (63)

Lost or reduced deep tendon reflexes

3/11 (27)